Discovery & Development

Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza

As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments

AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset

Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments

How digital health technology can help clinical trials be more inclusive and accessible.

Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

How a complex but common carbohydrate could help add a new dimension to 3D-printed pills

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality